Abbott ARCHITECT DHEA-S Reagent Recalled for False Infant Results
Abbott is recalling ARCHITECT DHEA-S Reagent because it may produce falsely elevated results when used on samples from infants up to 60 days old.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II. The hazard involves a risk of harm through inaccurate diagnostic results for a vulnerable population (infants), which fits the criteria for a High severity score where injury has not yet been reported.
Plain-English summary
Abbott Gmbh & Co. KG is recalling 10,153 units of ARCHITECT DHEA-S Reagent. This product is a chemiluminescent microparticle immunoassay used for the quantitative determination of dehydroepiandrosterone sulfate (DHEA-S) in human serum and plasma on the ARCHITECT iSystem.
The recall was initiated because falsely elevated results may be obtained when using the assay with samples from infants up to 60 days old. The affected lots were distributed worldwide to numerous countries and to specific U.S. states, including Alabama, Arizona, California, and others.
Healthcare facilities and laboratories should check their inventory for the specific lot numbers and expiration dates listed in the recall notice. Users should stop using the affected reagent for testing infant samples up to 60 days old to prevent inaccurate diagnostic results.
The recalled product
- Product
- ARCHITECT DHEA-S Reagent Product Usage: It is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of dehydroepiandrosterone sulfate (DHEA-S) in human serum and plasma on the ARCHITECT iSystem.
- Manufacturer
- Abbott Gmbh & Co. KG
- Hazard
- Affected units
- 10,153
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- List No. 8K2-20 with the following Lot No.
- Exp. Date
- UDI: a. Lot No. 01316K000
- Exp. Date 04FEB2018
- UDI (01) 00380740017446 (17) 180204 (10) 01316K000 (240) 8K2720
- b. Lot No. 01217A000
- Exp. Date 13APR2018
- UDI (01) 00380740017446 (17) 180413 (10) 01217A000 (240) 8K2720
- c. Lot No. 02217D000
- Exp. Date 24JUN2018
- UDI (01) 00380740017446 (17) 180624 (10) 02217D000 (240) 8K2720
- d. Lot No. 04117H000
- Exp. Date 25NOV2018
- UDI (01) 00380740017446 (17) 181125 (10) 04117H000 (240) 8K2720
- List No. 8K27-25 with the following Lot No.
- UDI: a. Lot No. 01216K000
- UDI (01) 00380740017453 (17) 180204 (10) 01216K000 (240) 8K2725
- b. Lot No. 01117A000
- UDI (01) 00380740017453 (17) 180413 (10) 01117A000 (240) 8K2725
- c. Lot No. 02217C000
Distribution
Related recalls
Same manufacturer · Abbott Gmbh & Co. KG
See all →- HighAbbott Alinity ci System Control Module Recalled for Quality Control Failures
FDA (Devices) · 2020-08-05
- HighAbbott Alinity C Processing Module Recalled for Incorrect Patient Results
FDA (Devices) · 2020-06-24
- HighAbbott Recalls Architect iGentamicin Reagent Kits Due to Assay Interaction
FDA (Devices) · 2020-06-03
- ModerateAbbott Recalls Architect HAVAB G Reagent Kits Due to Antigen Concentration Error
FDA (Devices) · 2020-04-29
- HighAbbott Alinity ci-series Software Recalled for Performance Issues
FDA (Devices) · 2020-04-01
Same hazard · inaccurate results
See all →- HighHealthmark Protein Test Recalled Due to Expired Ingredient
FDA (Devices) · 2026-09-02
- HighHardyDisk AST Cefiderocol 30µg for In Vitro Testing Recalled Due to Incorrect Cartridges
FDA (Devices) · 2026-08-12
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- Highepoc BGEM BUN Test Card for epoc Blood Analysis System
FDA (Devices) · 2026-05-06
- HighAbbott i-STAT EG7+ Blood Gas Cartridges Reporting Inaccurate Results
FDA (Devices) · 2026-05-06